We sought to examine the genetic contribution of MYC to the development and progression of primary PCa in the context of dysregulated growth by using anti-MYC immunohistochemistry (IHC) and performing laser capture microdissection on populations of human prostate tumor cells with varying expression of MYC protein. This evidence concerns the gene MYC and posterior cortical atrophy.